PSC Energy Corp. says it has received approval from the Federal Energy Regulatory Commission to sell energy pills to customers that contain the drug dte-3, the company announced Monday.
Energy pills sold through PSC’s online pharmacy site are designed to help people take a powerful medication called dte.
Dte is a common painkiller prescribed to treat chronic pain.
“PSC is committed to delivering a safe, effective and convenient way to treat pain and promote wellness, including dte,” the company said in a statement.
The approval comes about a year after the FDA announced that it would begin testing dte pills as a possible new treatment for certain types of chronic pain, including post-traumatic stress disorder.
For the last five years, the FDA has been evaluating dte for the use in treating certain types or conditions of chronic fatigue syndrome, or PTSD.
Last year, the agency approved dte as a treatment for chronic pain and the symptoms of PTSD.PSC said it expects to have dte available by the end of the year.
In December, PSC said the drug’s manufacturers are still in talks with the FDA on the approval process.
PSC has also made progress in recent months on the development of dte and its efficacy, PSA said.
According to PSA, the drugs currently in clinical trials are dte, dteplus, dt2-delta and dte3.
As a result of these efforts, Psc plans to begin marketing dte by the first quarter of 2019.
If the FDA approves the dte medications, Psa said it would be the first time in the United States that the FDA will allow a generic version of the medication to be sold.